{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T05:41:33Z","timestamp":1768369293596,"version":"3.49.0"},"reference-count":94,"publisher":"Georg Thieme Verlag KG","issue":"01","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Thromb Hemost"],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Chronic use of multiple drugs increases risk of adverse drug reactions, drug interactions and poor therapeutic adherence. In elderly or frail patients, some drugs may become ineffective or even harmful with advancing age and worsening clinical conditions. Nonsteroidal anti-inflammatory drugs (NSAIDs) have been extensively used for decades and, as a class, are both often inappropriately prescribed and involved in polypharmacotherapy untoward effects. In view of the dynamic and mutual relationship between inflammation and hemostasis in various clinical scenarios, use of anti-inflammatory agents, including NSAIDs, may tip this difficult balance in patients with hemostatic disorders. Rather than on well-established actions such as the clinically relevant antiplatelet action of low-dose aspirin and gastrointestinal bleeding, this review focuses on less highlighted, emerging or sometimes overlooked NSAID efficacy and safety endpoints. For instance, preclinical studies suggest that the antiplatelet action of low-dose aspirin enhances immune system activity against cancer cells, resulting in metastasis prevention. While use of NSAIDs in patients with coagulation disorders may have an acceptable risk-to-benefit ratio in selected patients, clinical judgement is required especially in cases of renal impairment that can be worsened by NSAIDs or in cases with high bleeding risk. In the context of polypharmacotherapy, attenuation of aspirin antiplatelet action by concomitant and inaccurately timed ibuprofen treatment may undermine the clinical benefit of aspirin in cardiovascular prevention. Thus, collaborative cross-disciplinary efforts of pharmacologists and clinicians would be desirable in order to enhance appropriateness, efficacy and safety of NSAID treatment in different settings of care.<\/jats:p>","DOI":"10.1055\/a-2725-6989","type":"journal-article","created":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T23:22:42Z","timestamp":1761261762000},"page":"035-045","source":"Crossref","is-referenced-by-count":0,"title":["Risks and Benefits of Nonsteroidal Anti-inflammatory Drugs in the Hemostatic System"],"prefix":"10.1055","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4820-4876","authenticated-orcid":false,"given":"Andrea","family":"Cignarella","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Padova, Padova, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Campello","sequence":"additional","affiliation":[{"name":"Internal Medicine 1, Thrombotic and Hemorrhagic Diseases Unit, Department of Medicine, Padova University Hospital, Padova, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni Eugenio","family":"Ramaschi","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Padova, Padova, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Simion","sequence":"additional","affiliation":[{"name":"Internal Medicine 1, Thrombotic and Hemorrhagic Diseases Unit, Department of Medicine, Padova University Hospital, Padova, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Simioni","sequence":"additional","affiliation":[{"name":"Internal Medicine 1, Thrombotic and Hemorrhagic Diseases Unit, Department of Medicine, Padova University Hospital, Padova, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2025,11,10]]},"reference":[{"issue":"05","key":"ref2","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s40520-022-02094-z","article-title":"Italian guidelines on management of persons with multimorbidity and polypharmacy","volume":"34","author":"G Onder","year":"2022","journal-title":"Aging Clin Exp Res"},{"issue":"13","key":"ref3","doi-asserted-by":"crossref","first-page":"7563","DOI":"10.1073\/pnas.96.13.7563","article-title":"Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis","volume":"96","author":"T D Warner","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"06","key":"ref4","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1056\/NEJM200108093450607","article-title":"The coxibs, selective inhibitors of cyclooxygenase-2","volume":"345","author":"G A FitzGerald","year":"2001","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"S423","DOI":"10.1194\/jlr.R800094-JLR200","article-title":"Prostanoids in health and disease","volume":"50","author":"E M Smyth","year":"2009","journal-title":"J Lipid Res"},{"issue":"22","key":"ref6","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1056\/NEJMra052717","article-title":"Low-dose aspirin for the prevention of atherothrombosis","volume":"353","author":"C Patrono","year":"2005","journal-title":"N Engl J Med"},{"issue":"02","key":"ref7","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1096\/fj.07-8506com","article-title":"Acetaminophen (paracetamol) is a selective cyclooxygenase-2 inhibitor in man","volume":"22","author":"B Hinz","year":"2008","journal-title":"FASEB J"},{"issue":"08","key":"ref8","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.tips.2017.05.008","article-title":"The cardiovascular pharmacology of nonsteroidal anti-inflammatory drugs","volume":"38","author":"T Grosser","year":"2017","journal-title":"Trends Pharmacol Sci"},{"issue":"04","key":"ref9","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.bbalip.2014.09.016","article-title":"Cyclooxygenase inhibitors: from pharmacology to clinical read-outs","volume":"1851","author":"P Patrignani","year":"2015","journal-title":"Biochim Biophys Acta"},{"issue":"09","key":"ref10","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/s41569-020-0366-z","article-title":"Cardiovascular effects and safety of (non-aspirin) NSAIDs","volume":"17","author":"A M Schjerning","year":"2020","journal-title":"Nat Rev Cardiol"},{"issue":"06","key":"ref11","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1161\/ATVBAHA.119.313234","article-title":"Cardiovascular biology of prostanoids and drug discovery","volume":"40","author":"L Zhu","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"01","key":"ref12","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1046\/j.1365-2125.2003.02007.x","article-title":"Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications","volume":"57","author":"A A Mangoni","year":"2004","journal-title":"Br J Clin Pharmacol"},{"issue":"06","key":"ref13","first-page":"1257","article-title":"Experimental pain in healthy human subjects: gender differences in nociception and in response to ibuprofen","volume":"86","author":"J S Walker","year":"1998","journal-title":"Anesth Analg"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"874606","DOI":"10.3389\/fphar.2022.874606","article-title":"Harnessing clinical trial and real-world data towards an understanding of sex effects on drug pharmacokinetics, pharmacodynamics and efficacy","volume":"13","author":"J Oi Yan Chan","year":"2022","journal-title":"Front Pharmacol"},{"issue":"01","key":"ref15","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nri3345","article-title":"Thrombosis as an intravascular effector of innate immunity","volume":"13","author":"B Engelmann","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.thromres.2016.11.007","article-title":"Coagulation and sepsis","volume":"149","author":"M Levi","year":"2017","journal-title":"Thromb Res"},{"issue":"03","key":"ref17","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/rth2.12109","article-title":"The coagulation system in host defense","volume":"2","author":"S Antoniak","year":"2018","journal-title":"Res Pract Thromb Haemost"},{"issue":"04","key":"ref18","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1365-2141.2005.05753.x","article-title":"The interactions between inflammation and coagulation","volume":"131","author":"C T Esmon","year":"2005","journal-title":"Br J Haematol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1097\/CCM.0b013e3181c98d21","article-title":"Inflammation and coagulation","volume":"38","author":"M Levi","year":"2010","journal-title":"Crit Care Med"},{"issue":"08","key":"ref20","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1111\/jth.14157","article-title":"Regulation of plasminogen activation on cell surfaces and fibrin","volume":"16","author":"T Urano","year":"2018","journal-title":"J Thromb Haemost"},{"issue":"12","key":"ref21","doi-asserted-by":"crossref","first-page":"5087","DOI":"10.1182\/blood-2006-12-027698","article-title":"The growing complexity of platelet aggregation","volume":"109","author":"S P Jackson","year":"2007","journal-title":"Blood"},{"issue":"36","key":"ref22","doi-asserted-by":"crossref","first-page":"15880","DOI":"10.1073\/pnas.1005743107","article-title":"Extracellular DNA traps promote thrombosis","volume":"107","author":"T A Fuchs","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"03","key":"ref23","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41569-018-0110-0","article-title":"Platelet biology and functions: new concepts and clinical perspectives","volume":"16","author":"P EJ van der Meijden","year":"2019","journal-title":"Nat Rev Cardiol"},{"issue":"02","key":"ref24","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.thromres.2015.05.029","article-title":"Circulating microparticles in umbilical cord blood in normal pregnancy and pregnancy with preeclampsia","volume":"136","author":"E Campello","year":"2015","journal-title":"Thromb Res"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"770463","DOI":"10.3389\/fcell.2021.770463","article-title":"Longitudinal trend of plasma concentrations of extracellular vesicles in patients hospitalized for COVID-19","volume":"9","author":"E Campello","year":"2022","journal-title":"Front Cell Dev Biol"},{"issue":"10","key":"ref26","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1161\/CIRCRESAHA.110.233056","article-title":"Microparticles in hemostasis and thrombosis","volume":"108","author":"A P Owens III","year":"2011","journal-title":"Circ Res"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s40560-019-0387-z","article-title":"Sepsis-associated disseminated intravascular coagulation and its differential diagnoses","volume":"7","author":"T Iba","year":"2019","journal-title":"J Intensive Care"},{"issue":"21","key":"ref28","doi-asserted-by":"crossref","first-page":"12906","DOI":"10.3390\/ijms232112906","article-title":"The role of inflammation in cardiovascular disease","volume":"23","author":"M Y Henein","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"05","key":"ref29","doi-asserted-by":"crossref","first-page":"e35296","DOI":"10.1371\/journal.pone.0035296","article-title":"Autoantibody epitope spreading in the pre-clinical phase predicts progression to rheumatoid arthritis","volume":"7","author":"J Sokolove","year":"2012","journal-title":"PLoS One"},{"issue":"02","key":"ref30","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1182\/bloodadvances.2024014430","article-title":"CHIP away at the marrow-clot connection: inflammation, clonal hematopoiesis, and thromboembolic disease","volume":"9","author":"A Todorovski","year":"2025","journal-title":"Blood Adv"},{"issue":"05","key":"ref31","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.phrs.2009.01.011","article-title":"Nonsteroidal antiinflammatory drugs: past, present and future","volume":"59","author":"C Patrono","year":"2009","journal-title":"Pharmacol Res"},{"issue":"12","key":"ref32","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"P M Ridker","year":"2017","journal-title":"N Engl J Med"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"592","DOI":"10.3389\/fimmu.2016.00592","article-title":"Endothelial response to glucocorticoids in inflammatory diseases","volume":"7","author":"K A Zieli\u0144ska","year":"2016","journal-title":"Front Immunol"},{"issue":"04","key":"ref34","doi-asserted-by":"crossref","first-page":"e004838","DOI":"10.1136\/rmdopen-2024-004838","article-title":"Impaired coagulation parameters in early RA are restored by effective antirheumatic therapy: a prospective pilot study","volume":"10","author":"B Dijkshoorn","year":"2024","journal-title":"RMD Open"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0140-6736(13)60900-9","article-title":"Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials","volume":"382","author":"N Bhala","year":"2013","journal-title":"Lancet"},{"issue":"01","key":"ref36","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/hae.12526","article-title":"Managing chronic pain in adults with haemophilia: current status and call to action","volume":"21","author":"T J Humphries","year":"2015","journal-title":"Haemophilia"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.critrevonc.2016.02.002","article-title":"Is the cardiovascular toxicity of NSAIDS and COX-2 selective inhibitors underestimated in patients with haemophilia?","volume":"100","author":"A Boban","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"100987","DOI":"10.1016\/j.blre.2022.100987","article-title":"The fear for adverse bleeding and cardiovascular events in hemophilia patients using (non-)selective non-steroidal anti-inflammatory drugs: a systematic review reporting on safety","volume":"56","author":"E DP van Bergen","year":"2022","journal-title":"Blood Rev"},{"issue":"03","key":"ref39","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1365-2516.2007.01453.x","article-title":"Upper gastrointestinal bleeding in haemophiliacs: incidence and relation to use of non-steroidal anti-inflammatory drugs","volume":"13","author":"M E Eyster","year":"2007","journal-title":"Haemophilia"},{"issue":"02","key":"ref40","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/rth2.12298","article-title":"Hematuria in aging men with hemophilia: association with factor prophylaxis","volume":"4","author":"C Qvigstad","year":"2020","journal-title":"Res Pract Thromb Haemost"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/hae.14046","article-title":"WFH guidelines for the management of hemophilia, 3rd edition","volume":"26","author":"A Srivastava","year":"2020","journal-title":"Haemophilia"},{"issue":"04","key":"ref42","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/rheumatology\/keu408","article-title":"Non-steroidal anti-inflammatory drugs and risk of venous thromboembolism: a systematic review and meta-analysis","volume":"54","author":"P Ungprasert","year":"2015","journal-title":"Rheumatology (Oxford)"},{"issue":"01","key":"ref43","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1538-7836.2011.04544.x","article-title":"Neutrophil extracellular traps promote deep vein thrombosis in mice","volume":"10","author":"A Brill","year":"2012","journal-title":"J Thromb Haemost"},{"issue":"04","key":"ref44","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1084\/jem.20112322","article-title":"Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo","volume":"209","author":"M L von Br\u00fchl","year":"2012","journal-title":"J Exp Med"},{"issue":"21","key":"ref45","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1056\/NEJMoa1114238","article-title":"Aspirin for preventing the recurrence of venous thromboembolism","volume":"366","author":"C Becattini","year":"2012","journal-title":"N Engl J Med"},{"issue":"21","key":"ref46","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1056\/NEJMoa1210384","article-title":"Low-dose aspirin for preventing recurrent venous thromboembolism","volume":"367","author":"T A Brighton","year":"2012","journal-title":"N Engl J Med"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1126\/science.1103333","article-title":"COX-2-derived prostacyclin confers atheroprotection on female mice","volume":"306","author":"K M Egan","year":"2004","journal-title":"Science"},{"issue":"05","key":"ref48","doi-asserted-by":"crossref","first-page":"e157","DOI":"10.1371\/journal.pmed.0040157","article-title":"Traditional nonsteroidal anti-inflammatory drugs and postmenopausal hormone therapy: a drug-drug interaction?","volume":"4","author":"L A Garc\u00eda Rodr\u00edguez","year":"2007","journal-title":"PLoS Med"},{"issue":"02","key":"ref49","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/FJC.0b013e31820350d3","article-title":"Exogenous estrogen does not attenuate the association between rofecoxib and myocardial infarction in perimenopausal women","volume":"57","author":"K C Wade","year":"2011","journal-title":"J Cardiovasc Pharmacol"},{"issue":"05","key":"ref50","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1093\/ehjcvp\/pvz069","article-title":"Risk of gastrointestinal bleeding associated with oral anticoagulation and non-steroidal anti-inflammatory drugs in patients with atrial fibrillation: a nationwide study","volume":"6","author":"A S Olsen","year":"2020","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"issue":"01","key":"ref51","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1093\/eurheartj\/ehae736","article-title":"Bleeding risk using non-steroidal anti-inflammatory drugs with anticoagulants after venous thromboembolism: a nationwide Danish study","volume":"46","author":"S R Petersen","year":"2025","journal-title":"Eur Heart J"},{"issue":"05","key":"ref52","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1093\/ehjcvp\/pvab050","article-title":"Low-dose rivaroxaban plus aspirin in patients with polypharmacy and multimorbidity: an analysis from the COMPASS trial","volume":"8","author":"T Vanassche","year":"2022","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"issue":"07","key":"ref53","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1055\/s-0040-1710592","article-title":"Risk of bleeding with exposure to warfarin and nonsteroidal anti-inflammatory drugs: a systematic review and meta-analysis","volume":"120","author":"L Villa Zapata","year":"2020","journal-title":"Thromb Haemost"},{"issue":"09","key":"ref54","doi-asserted-by":"crossref","first-page":"701","DOI":"10.2165\/00002512-200320090-00006","article-title":"NSAID and aspirin use by the elderly in general practice: effect on gastrointestinal symptoms and therapies","volume":"20","author":"A Pilotto","year":"2003","journal-title":"Drugs Aging"},{"issue":"23","key":"ref55","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1182\/bloodadvances.2019000966","article-title":"American Society of Hematology 2019 guidelines for immune thrombocytopenia","volume":"3","author":"C Neunert","year":"2019","journal-title":"Blood Adv"},{"issue":"09","key":"ref56","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1111\/jth.14227","article-title":"Risk factors for bleeding, including platelet count threshold, in newly diagnosed immune thrombocytopenia adults","volume":"16","author":"M L Piel-Julian","year":"2018","journal-title":"J Thromb Haemost"},{"issue":"08","key":"ref57","doi-asserted-by":"crossref","first-page":"e750","DOI":"10.1097\/HS9.0000000000000750","article-title":"EHA guidelines on management of antithrombotic treatments in thrombocytopenic patients with cancer","volume":"6","author":"A Falanga","year":"2022","journal-title":"HemaSphere"},{"issue":"06","key":"ref58","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1021\/jm9607010","article-title":"Effect of structural modification of enol-carboxamide-type nonsteroidal antiinflammatory drugs on COX-2\/COX-1 selectivity","volume":"40","author":"E S Lazer","year":"1997","journal-title":"J Med Chem"},{"issue":"02","key":"ref59","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1002\/phar.1372","article-title":"Meloxicam-induced thrombocytopenia","volume":"34","author":"M M Ranieri","year":"2014","journal-title":"Pharmacotherapy"},{"issue":"07","key":"ref60","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1002\/cpdd.772","article-title":"Platelet function: meloxicam intravenous in whole blood samples from healthy volunteers","volume":"9","author":"J S Jahr","year":"2020","journal-title":"Clin Pharmacol Drug Dev"},{"issue":"03","key":"ref61","first-page":"649","article-title":"Severe generalized reactions to ibuprofen: report of a case","volume":"13","author":"J H Butterfield","year":"1986","journal-title":"J Rheumatol"},{"issue":"06","key":"ref62","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1097\/MBC.0000000000001241","article-title":"Left ventricular assist device thrombosis in the setting of supratherapeutic international normalized ratio (INR) and bleeding","volume":"34","author":"G Gupta","year":"2023","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"48","key":"ref63","doi-asserted-by":"crossref","first-page":"7725","DOI":"10.3748\/wjg.v12.i48.7725","article-title":"New insights into the coagulopathy of liver disease and liver transplantation","volume":"12","author":"M Senzolo","year":"2006","journal-title":"World J Gastroenterol"},{"issue":"01","key":"ref64","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1365-2125.2004.02133.x","article-title":"Acute and clinically relevant drug-induced liver injury: a population based case-control study","volume":"58","author":"F J de Abajo","year":"2004","journal-title":"Br J Clin Pharmacol"},{"issue":"07","key":"ref65","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1111\/bcp.14254","article-title":"Metamizole: an underrated agent causing severe idiosyncratic drug-induced liver injury","volume":"86","author":"M Sebode","year":"2020","journal-title":"Br J Clin Pharmacol"},{"issue":"03","key":"ref66","doi-asserted-by":"crossref","first-page":"e70012","DOI":"10.1111\/liv.70012","article-title":"Drug-induced liver injury caused by metamizole: identification of a characteristic injury pattern","volume":"45","author":"S Weber","year":"2025","journal-title":"Liver Int"},{"issue":"03","key":"ref67","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/cld.737","article-title":"Risk of nonsteroidal anti-inflammatory drugs and safety of acetaminophen in patients with advanced liver disease","volume":"12","author":"M H Malespin","year":"2018","journal-title":"Clin Liver Dis (Hoboken)"},{"issue":"02","key":"ref68","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1136\/gut.44.2.270","article-title":"Anti-inflammatory drugs and variceal bleeding: a case-control study","volume":"44","author":"V De L\u00e9dinghen","year":"1999","journal-title":"Gut"},{"issue":"06","key":"ref69","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.immuni.2022.04.015","article-title":"Activation of the transcription factor NRF2 mediates the anti-inflammatory properties of a subset of over-the-counter and prescription NSAIDs","volume":"55","author":"A Eisenstein","year":"2022","journal-title":"Immunity"},{"issue":"02","key":"ref70","first-page":"131","article-title":"Acetaminophen-induced hepatotoxicity: a comprehensive update","volume":"4","author":"E Yoon","year":"2016","journal-title":"J Clin Transl Hepatol"},{"issue":"07","key":"ref71","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1161\/01.RES.0000163015.67711.AB","article-title":"Activation of inflammation and coagulation after infusion of C-reactive protein in humans","volume":"96","author":"R J Bisoendial","year":"2005","journal-title":"Circ Res"},{"issue":"11","key":"ref72","doi-asserted-by":"crossref","first-page":"3511","DOI":"10.1002\/art.34644","article-title":"Effect of nonsteroidal antiinflammatory drugs on the C-reactive protein level in rheumatoid arthritis: a meta-analysis of randomized controlled trials","volume":"64","author":"S Tarp","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"01","key":"ref73","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1055\/s-2006-933339","article-title":"Tissue factor expression in the morphologic spectrum of vulnerable atherosclerotic plaques","volume":"32","author":"A C van der Wal","year":"2006","journal-title":"Semin Thromb Hemost"},{"issue":"11","key":"ref74","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1161\/CIRCULATIONAHA.112.097295","article-title":"Cyclooxygenase-2-derived prostacyclin regulates arterial thrombus formation by suppressing tissue factor in a sirtuin-1-dependent-manner","volume":"126","author":"S S Barbieri","year":"2012","journal-title":"Circulation"},{"issue":"13","key":"ref75","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1161\/01.CIR.0000160358.63804.C9","article-title":"Celecoxib decreases endothelial tissue factor expression through inhibition of c-Jun terminal NH2 kinase phosphorylation","volume":"111","author":"J Steffel","year":"2005","journal-title":"Circulation"},{"issue":"09","key":"ref76","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1084\/jem.20070828","article-title":"COX-2 suppresses tissue factor expression via endocannabinoid-directed PPARdelta activation","volume":"204","author":"M Ghosh","year":"2007","journal-title":"J Exp Med"},{"issue":"25","key":"ref77","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa003199","article-title":"Cyclooxygenase inhibitors and the antiplatelet effects of aspirin","volume":"345","author":"F Catella-Lawson","year":"2001","journal-title":"N Engl J Med"},{"issue":"47","key":"ref78","doi-asserted-by":"crossref","first-page":"16830","DOI":"10.1073\/pnas.1406997111","article-title":"Differential impairment of aspirin-dependent platelet cyclooxygenase acetylation by nonsteroidal antiinflammatory drugs","volume":"111","author":"X Li","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"03","key":"ref79","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/j.1552-4604.1995.tb04050.x","article-title":"Effects of nonsteroidal antiinflammatory drugs on platelet function and systemic hemostasis","volume":"35","author":"A I Schafer","year":"1995","journal-title":"J Clin Pharmacol"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"199S","DOI":"10.1378\/chest.08-0672","article-title":"Antiplatelet drugs: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)","volume":"133","author":"C Patrono","year":"2008","journal-title":"Chest"},{"issue":"06","key":"ref81","doi-asserted-by":"crossref","first-page":"497","DOI":"10.3109\/09537104.2016.1161739","article-title":"Regulation of platelet lifespan by apoptosis","volume":"27","author":"M Lebois","year":"2016","journal-title":"Platelets"},{"issue":"10","key":"ref82","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nri.2016.90","article-title":"Sex differences in immune responses","volume":"16","author":"S L Klein","year":"2016","journal-title":"Nat Rev Immunol"},{"issue":"05","key":"ref83","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.4049\/jimmunol.1601166","article-title":"Sex drives dimorphic immune responses to viral infections","volume":"198","author":"S Ghosh","year":"2017","journal-title":"J Immunol"},{"issue":"02","key":"ref84","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/SLA.0000000000000526","article-title":"Prehospital use of nonsteroidal anti-inflammatory drugs (NSAIDs) is associated with a reduced incidence of trauma-induced coagulopathy","volume":"260","author":"M D Neal","year":"2014","journal-title":"Ann Surg"},{"issue":"06","key":"ref85","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/jphp.12203","article-title":"Ibuprofen inhibits migration and proliferation of human coronary artery smooth muscle cells by inducing a differentiated phenotype: role of peroxisome proliferator-activated receptor \u03b3","volume":"66","author":"A Dannoura","year":"2014","journal-title":"J Pharm Pharmacol"},{"issue":"12","key":"ref86","first-page":"1587","article-title":"Activation of peroxisome proliferator-activated receptor isoforms and inhibition of prostaglandin H(2) synthases by ibuprofen, naproxen, and indomethacin","volume":"62","author":"M S Jaradat","year":"2001","journal-title":"Biochem Pharmacol"},{"issue":"03","key":"ref87","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1254\/jphs.93.347","article-title":"Evaluation of human peroxisome proliferator-activated receptor (PPAR) subtype selectivity of a variety of anti-inflammatory drugs based on a novel assay for PPAR \u03b4(\u03b2)","volume":"93","author":"H Kojo","year":"2003","journal-title":"J Pharmacol Sci"},{"issue":"05","key":"ref88","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/0092-8674(95)90194-9","article-title":"A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor \u03b3 and promotes adipocyte differentiation","volume":"83","author":"S A Kliewer","year":"1995","journal-title":"Cell"},{"issue":"01","key":"ref89","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1124\/mol.61.1.7","article-title":"Diclofenac antagonizes peroxisome proliferator-activated receptor-\u03b3 signaling","volume":"61","author":"D J Adamson","year":"2002","journal-title":"Mol Pharmacol"},{"key":"ref90","doi-asserted-by":"crossref","first-page":"106506","DOI":"10.1016\/j.phrs.2022.106506","article-title":"The specific deletion of cyclooxygenase-1 in megakaryocytes\/platelets reduces intestinal polyposis in ApcMin\/+ mice","volume":"185","author":"A Bruno","year":"2022","journal-title":"Pharmacol Res"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1038\/s41586-025-08626-7","article-title":"Aspirin prevents metastasis by limiting platelet TXA2 suppression of T cell immunity","volume":"640","author":"J Yang","year":"2025","journal-title":"Nature"},{"issue":"33","key":"ref92","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1093\/eurheartj\/ehaf054","article-title":"Distinct inflammatory pathways shape atherosclerosis in different vascular beds","volume":"46","author":"O Soehnlein","year":"2025","journal-title":"Eur Heart J"},{"key":"ref93","doi-asserted-by":"crossref","first-page":"106956","DOI":"10.1016\/j.phrs.2023.106956","article-title":"Sex-oriented perspectives in immunopharmacology","volume":"197","author":"A Cignarella","year":"2023","journal-title":"Pharmacol Res"},{"issue":"03","key":"ref94","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.tips.2009.11.007","article-title":"Dual COXIB\/TP antagonists: a possible new twist in NSAID pharmacology and cardiovascular risk","volume":"31","author":"G E Rovati","year":"2010","journal-title":"Trends Pharmacol Sci"},{"issue":"21","key":"ref95","doi-asserted-by":"crossref","first-page":"23185","DOI":"10.1021\/acs.jmedchem.5c02068","article-title":"Exploiting the 2-(1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl) acetic acid scaffold to generate COXTRANs: a new class of dual cyclooxygenase inhibitors-thromboxane receptor antagonists","volume":"68","author":"F Blua","year":"2025","journal-title":"J Med Chem"}],"container-title":["Seminars in Thrombosis and Hemostasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2725-6989.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T23:31:54Z","timestamp":1768347114000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2725-6989"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,23]]},"references-count":94,"journal-issue":{"issue":"01","published-online":{"date-parts":[[2026,1,13]]},"published-print":{"date-parts":[[2026,2]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2725-6989","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0094-6176","1098-9064"],"issn-type":[{"value":"0094-6176","type":"print"},{"value":"1098-9064","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,10,23]]},"published":{"date-parts":[[2025,10,23]]}}}